Serial #79289025
LIVE

Serial Number

79289025

Owner

Helixgen(Guangzhou)Co.,Ltd.

Attorney

Zhi Dong

Filing Date

May 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79289025 Trademark

Serial Number: 79289025 • Registration: 6585336

Serial #79289025 is a trademark filed by Helixgen(Guangzhou)Co.,Ltd. on May 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Helixgen(Guangzhou)Co.,Ltd. (2 trademarks)

Unit 901, C2 No. 182 Kexue Ave.

Entity Type: 99

Trademark Details

Filing Date

May 7, 2020

Registration Date

December 14, 2021

Published for Opposition

September 28, 2021

Goods & Services

Nutritive substances for microorganisms for medical purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of colorectal diseases and colorectal cancer; biological preparations for medical purposes for the treatment of colorectal diseases and colorectal cancer; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes for the treatment of colorectal diseases and colorectal cancer; enzyme preparations for medical purposes

Diagnostic apparatus for medical purposes, namely, diagnostic apparatus for the detection and screening of tumors, and medical diagnostic apparatus for testing tumor cells and DNA; blood testing apparatus; hemocytometers; sphygmomanometers; apparatus for use in medical analysis, namely, apparatus for analyzing blood, body fluid and excrement, and medical diagnostic apparatus for analyzing and measuring tumor cells in the blood, body fluid and excrement samples; testing apparatus for medical purposes, namely, testing apparatus for blood, body fluid and excrement, medical diagnostic apparatus for testing DNA and RNA samples, and tumor cells testing apparatus for medical use; medical apparatus and instruments, namely, medical apparatus and instruments for monitoring characteristic of blood, body fluid and excrement, medical apparatus and instruments for treating cancers, medical apparatus and instruments for preventing or reversing cancers, and medical apparatus and instruments for measuring and displaying tumor cells in the blood, body fluid and excrement samples; bottles for taking samples for medical use, namely, medical sterile specimen containers, sold empty; respirators for artificial respiration; apparatus for artificial respiration

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 21, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 25, 2022 FICS
FINAL DISPOSITION PROCESSED
May 24, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 14, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 14, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Oct 25, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 28, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 22, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 22, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2021 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 20, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 20, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 20, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2021 TROA
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 31, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 3, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 3, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 14, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2020 REPR